Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/f-18-fdg-pet-ct-in-nk-t-cell-lymphoma-that-progressed-from-epstein-ZX15OQRMEv
References (14)
-
Leilei Yuan, Y. Kan, J. Meeks, D. Ma, Ji-gang Yang (2016)
18F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis.Diagnostic and interventional radiology, 22 5
-
(2020)
18-FDG PET/CT findings in hemophagocytic lymphohistiocytosis: a pictorial review -
M. Jordan, C. Allen, Jay Greenberg, Michael Henry, M. Hermiston, Ashish Kumar, M. Hines, O. Eckstein, S. Ladisch, K. Nichols, C. Rodríguez-Galindo, B. Wistinghausen, K. McClain (2019)
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)Pediatric Blood & Cancer, 66
-
Jiann‐Shiuh Chen, K. Lin, D. Lin, Rong-Long Chen, S. Jou, I. Su (1998)
Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide‐containing regimensBritish Journal of Haematology, 103
-
Jahae Kim, S. Yoo, Sae-Ryung Kang, H. Bom, Ho-Chun Song, J. Min (2014)
Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosisAnnals of Hematology, 93
-
H. Chuang, J. Lay, W. Hsieh, I. Su (2007)
Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein–Barr virus‐associated T‐cell lymphoma: Nuclear factor‐κB pathway as a potential therapeutic targetCancer Science, 98
-
S. Basu, T. Chryssikos, S. Moghadam-Kia, H. Zhuang, D. Torigian, A. Alavi (2009)
Positron emission tomography as a diagnostic tool in infection: present role and future possibilities.Seminars in nuclear medicine, 39 1
-
L Qiu (2017)
1096 LP - 1096J Nucl Med, 58
-
Jujuan Wang, Dongjiao Wang, Qingbo Zhang, L. Duan, T. Tian, Xiao-yan Zhang, Jianyong Li, Hongxia Qiu (2015)
The significance of pre-therapeutic F-18-FDG PET–CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailableJournal of Cancer Research and Clinical Oncology, 142
-
L Qiu, Q Wang (2017)
Can 18F-FDG PET/CT distinguish the cause of the hemophagocytic lymphohistiocytosisJ Nucl Med, 58
-
J. Henter, A. Horne, M. Aricò, R. Egeler, A. Filipovich, S. Imashuku, S. Ladisch, K. McClain, D. Webb, J. Winiarski, G. Janka (2007)
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 48
-
M. Ramos-Casals, P. Brito‐Zerón, A. López-Guillermo, M. Khamashta, X. Bosch (2014)
Adult haemophagocytic syndromeThe Lancet, 383
-
H Recht (2020)
1140 LP - 1140J Nucl Med, 61
-
Y. Zheng, Guilan Hu, Yong Liu, Yanru Ma, Yonghong Dang, Fang Li, Haiqun Xing, Tong Wang, L. Huo (2016)
The role of 18F-FDG PET/CT in the management of patients with secondary haemophagocytic lymphohistiocytosis.Clinical radiology, 71 12
- Publisher
- Springer Journals
- Copyright
- Copyright © Korean Society of Nuclear Medicine 2021
- ISSN
- 1869-3474
- eISSN
- 1869-3482
- DOI
- 10.1007/s13139-021-00725-3
- Publisher site
- See Article on Publisher Site
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome involving an uncontrolled immune response with variable triggers. HLH is rare but highly fatal, even with proper treatment; therefore, early recognition and diagnosis are crucial for management. Although the role of F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in HLH is poorly defined, it can provide valuable information on disease status and possible triggers. Herein, we report an F-18 FDG PET/CT study on a case of NK/T-cell lymphoma that progressed from Epstein-Barr virus-associated HLH.
Journal
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Feb 1, 2022
Keywords: F-18 FDG PET/CT; Hemophagocytic lymphohistiocytosis; Epstein-Barr virus; NK/T-cell lymphoma